Pharma
‹ Back

Growth in Biotech: Argenx's E2E Supply Network Planning Optimization

22 Apr 2026 Biotech

Introduction

Argenx, a fast-growing biotech, needed an end-to-end supply network planning capability that could keep pace with global expansion and an evolving product portfolio.

Solutions

  • End-to-end network model connecting internal and external nodes
  • Scenario-driven S&OP with clear decision cadence
  • CMO collaboration built into the planning workflow

Results

  • Faster, more confident launch and scale-up decisions
  • Improved visibility across the external manufacturing network

Other Case Studies

Contact Us

Lorem ipsum dolor sit amet consectetur. Nisi mi pellentesque tincidunt nisi nibh diam tincidunt in.